Supplementary Files
Keywords
Asthma
Bronchopulmonary aspergillosis
Steroids
Abstract
Background: Inflammation caused by chronic diseases and the constant use of systemic corticosteroids could be linked to the increased incidence of venous thromboembolic disease.
Clinical case: A 47 year-old man with severe asthma of difficult control and allergic bronchopulmonary aspergillosis who, although the treatment was optimal, continued to have recurrent exacerbations and the need for systemic corticosteroids. He had edema in his left leg. Through venous Doppler ultrasound, deep vein thrombosis was confirmed; because of the images of the pulmonary V/Q gammagram, the presence of chronic pulmonary thromboembolism was suspected. 5 mg of apixaban were prescribed every 12 hours; in less than two months, symptom control was achieved without hospitalization, systemic corticosteroids or short-acting B2 agonists. Gradual withdrawal of omalizumab was started with good tolerance.
Conclusions: The important decrease of bronchial symptoms with the blood thinner confirmed the suspicion that the exacerbations were caused by chronic pulmonary thromboembolism.
References
Global Initiative for Asthma. Global strategy for asthma management and prevention. Suiza: Global Initiative for Asthma; 2017.
Knutsen AP. Allergic bronchopulmonary aspergillosis in asthma. Expert Rev Clin Immunol. 2017;13(1):11-14. DOI: 10.1080/1744666X.2017.1232620
Saibeni S, Saladino V, Chantarangkul V, Villa F, Bruno S, Vecchi M, et al. Increased thrombin generation in inflammatory bowel diseases. Thromb Res. 2010;125(3):278-282. DOI: 10.1016/j.thromres.2009.10.012
Matta F, Singala R, Yaekoub AY, Najjar R, Stein PD. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost. 2009;101(1):134-138.
Majoor CJ, Kamphuisen PW, Zwinderman AH, Ten Brinke A, Amelink M, Rijssenbeek-Nouwens L, et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J. 2013;42(3):655-661. DOI: 10.1183/09031936.00150312
De Boer JD, Majoor CJ, van’t Veer C, Bel EH, Van Der Poll T. Asthma and coagulation. Blood. 2012;119(14):3236-3244. DOI: 10.1182/blood-2011-11-391532
Sneeboer MMS, Majoor CJ, De Kievit A, Meijers JCM, Van der-Poll T, Kamphuisen PW, et al. Prothrombotic state in patients with severe and prednisolone-dependent asthma. J Allergy Clin Immunol. 2016;137(6):1727-1732. DOI: 10.1016/j.jaci.2015.10.038
Chung WS, Lin CL, Ho FM, Li RY, Sung FC, Kao CH, et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J. 2014;43(3):801-807. DOI: 10.1183/09031936.00043313
Schouten M, van de Pol MA, Levi M, van der Poll T, van der Zee JS. Early activation of coagulation after allergen challenge in patients with allergic asthma. J Thromb Haemost. 2009;7(9):1592-1594. DOI: 10.1111/j.1538-7836.2009.03523.x
Wanner A, Mendes ES. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. Am J Respir Crit Care Med. 2010;182(11):1344-1351. DOI: 10.1164/rccm.201001-0038PP
Brims FJ, Chauhan AJ, Higgins B, Shute JK. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Thorax. 2009;64(12):1037-1043. DOI: 10.1136/thx.2009.114439
van Zaane B, Nur E, Squizzato A, Gerdes VE, Büller HR, Dekkers OM, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors. J Thromb Haemost 2010;8(11):2483-2493. DOI: 10.1111/j.1538-7836.2010.04034.x
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2019 Revista Alergia México